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Alzheimer’s disease (AD) is a neurodegenerative disease that affects more
than five million individuals in the United States alone, where it is the sixth
leading cause of death. While there is currently no cure for the disease, it is a
highly investigated topic of research. The Drosophila melanogaster eye model
is an excellent system to study AD, due to the highly conserved genetic
machinery shared between flies and humans. We have developed a
transgenic fly model of AD in which we use the GAL4/UAS system to
misexpress high levels of human Aβ42 peptides in the differentiating
photoreceptor neurons in the fly eye. We use this system to determine
whether modulating the function of the calcium signaling pathway can modify
Aβ42 mediated neurodegeneration. We used RNAi to knock down six
components of the calcium signaling pathway (stimRNAi, sercaRNAi, oraiRNAi,
inx2RNAi, ip3rRNAi, and plc 21cRNAi) in an Aβ42 background in the eye and
observed the effects in both eye antennal imaginal discs and adult eyes. Our
results showed evidence that knocking down components of the calcium
signaling pathway may ameliorate the neurodegeneration mediated by Aβ42.
Aberrant calcium signaling has also been implicated in cancer and other
neurological diseases besides AD. Our research further implicates intracellular
calcium signaling in neurodegenerative disorders such as AD. Further
research will determine the molecular mechanisms linking calcium signaling
with Ab42 mediated neurodegeneration.
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Gene Function
plc21c Catalyzes hydrolysis of PIP2 into IP3
and DAG
orai Located in the plasma membrane 
and intakes the calcium into the 
cytoplasm
stim Regulates calcium in ER 
and binds with orai to form CRAC
serca Regulates calcium intake into ER
ip3r Releases calcium from the ER into 
cytoplasm
inx2 Gap junction communication
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• Alzheimer’s disease (AD) is the sixth leading cause of death in the United
States and has no known cure.
• More than 5.7 million Americans have AD.
• Throughout the brain normal deposits of proteins form amyloid plaques and
tau tangles.
• This leads to neuronal cell death.
Future directions
• Downregulating the levels of expression of the six
components (stimRNAi, sercaRNAi, oraiRNAi, inx2RNAi,
ip3rRNAi, and plc 21cRNAi) of the calcium signaling
pathway demonstrated evidence of rescue of the Aβ42
phenotype in fly eye (animals reared at 29°C).
• Our results suggest that inactivation of calcium signaling
pathway may block Aβ42-mediated neurodegeneration.
• This has relevance for design of treatments for AD.
• Significance: Our studies show a role for calcium
signaling pathway in neurodegeneration disorders such
as Alzheimer's.
• Misexpress proteins involved in calcium signaling in flies 
expressing Aβ42 and determine the effect on adult eyes 
and eye discs.
• Determine the mechanism of action by which the 
intracellular calcium signaling pathway is involved in the 
progression of Alzheimer's disease.
Why use Drosophila?
• Many genes are conserved between flies and humans.
• Flies have less genetic redundancy.
• Basic cell biological pathways are nearly identical in flies and humans (eye 
specification, cell cycle, Ras, p53, InR signaling...)
• Ideal human disease model for genome wide genetic screens.
1933 Thomas Hunt Morgan uncovered the role played by chromosomes in heredity
1946 Hermann Joseph Muller used X-ray irradiation to increase mutation rates in fruit flies
1995 Edward B Lewis, Christiane Nüsslein-Volhard, and Eric F Wieschaus used 
drosophila to understand genetic control of embryonic development
2004 Richard Axel concentrated on odour receptors and the organisation of the olfactory 
system
2011 Jules A Hoffmann for his research on the activation of innate immunity
2017 Jeffrey C Hall, Michael Rosbash and Michael W Young uncovered the molecular 
mechanisms that control circadian rhythms.
• Calcium is an important component for cellular signaling. Multiple 
pathways control calcium concentration within the given areas.
• Alzheimer's associated peptide amyloid beta disrupts many pathways 
involved in calcium signaling leading to higher calcium concentration in 
the cytoplasm. 
• The higher cytosolic calcium concentration potentially leads to 
mitochondrial dysfunction and apoptosis.
• This contributes to the development and progression of Alzheimer's 
disease.
Gal4-UAS system
• Human Aβ42 gene was inserted into the Drosophila genome
• Able to test the effect on AD, when downregulating the expression of genes 
related to calcium signaling pathway.
• Control: GMR-GAL4
• Directs expression of target transgenes in the neurons of the developing 
retina.
Results
Approach: Use RNAi to knock down components of the calcium signaling 
pathway in flies expressing Aβ42 in retinal neurons and determine the effects 
on the eye-antennal imaginal disc and adult eye. 
(Sidiropoulos et al. 2017 PMID: 29077811 Reactome ID R-HSA-9006925)
(Caldwell et al. 2013)
